A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects

Clinical trial NCT05569941 · COMPLETED

Trial details

NCT number: NCT05569941
Sponsor: Assembly Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2022-11-11
Primary completion: 2023-04-12
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.